51 results on '"Parisi R"'
Search Results
2. Researcher at University Hospital Reports Research in Artificial Intelligence [Artificial intelligence (AI)-enhanced electrocardiography: a machine-learning model for differential diagnosis between hypertrophic cardiomyopathy, cardiac ...]
3. Almirall's Ilumetri (tildrakizumab) Restores and Maintains Wellbeing of Patients With Moderate-to-severe Plaque Psoriasis to the Levels of the General Population for up to 1 Year1
4. Research from Cardiology Unit in Heart Disease Provides New Insights (Incremental value of myocardial work analysis for detection of coronary artery disease during dipyridamole stress echocardiography)
5. CLARKSON UNIVERSITY REH SCHOOL OF BUSINESS FACULTY ACHIEVEMENTS FOR FALL 2021
6. New Dementia Study Findings Reported from Mayo Clinic (Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures)
7. Novartis Cosentyx(R) receives EU approval for first-line systemic treatment in pediatric psoriasis
8. Novartis Cosentyx(R) gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile
9. Galderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing
10. Galderma global research reveals struggles of people with rosacea and psoriasis of the face experiencing a lack of control and impact on mental wellbeing
11. New Findings from Mayo Clinic Describe Advances in Alzheimer Disease (The Value of Multimodal Imaging With I-123-fp-cit Spect In Differential Diagnosis of Dementia With Lewy Bodies and Alzheimer's Disease Dementia)
12. Karolinska Institutet: New publication: Prevalence of maternal mental illness among children and adolescents
13. Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study
14. Research Conducted at Mayo Clinic Has Updated Our Knowledge about Lewy Body Disease (Subtypes of Dementia With Lewy Bodies Are Associated With Alpha-synuclein and Tau Distribution)
15. Janssen Announces New Three-Year TREMFYA (Guselkumab) Data Demonstrates Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
16. Researchers at State University of Maringa Report Findings in Contractile Proteins (Pathway-oriented action of dietary essential oils to prevent muscle protein oxidation and texture deterioration of farmed rainbow trout)
17. New TREMFYA (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
18. New Two-Year TREMFYA(TM) (guselkumab) Data Show Patients With Moderate To Severe Plaque Psoriasis Achieved Consistent Rates Of Skin Clearance
19. New NADPH Oxidoreductases NADH Findings from University of Naples Federico II Described (Formyl Peptide Receptor 1 Modulates Endothelial Cell Functions by NADPH Oxidase-Dependent VEGFR2 Transactivation)
20. Janssen Submits Application Seeking FDA Approval Of Stelara (Ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis
21. Janssen Submits Application Seeking FDA Approval of STELARA (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
22. Janssen Submits Application To FDA Seeking Approval Of Anti-Interleukin-23 Monoclonal Antibody Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis
23. Oral OTEZLA[R] (Apremilast) Receives Positive Nice Recommendation for Adults with Chronic Plaque Psoriasis
24. LEO Pharma Receives Scientific Approval of Enstilar for the Treatment of Psoriasis in EU
25. Researchers from University of Naples Federico II Report Findings in Science (Co-Culture of Plant Beneficial Microbes as Source of Bioactive Metabolites)
26. New Tissue Engineering Study Findings Have Been Reported by Investigators at University of Parma [Anti-fibronectin aptamers improve the colonization of chitosan films modified with D-(+) Raffinose by murine osteoblastic cells]
27. LEO Pharma Inc. Announces FDA Approval of Enstilar(Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% for Plaque Psoriasis
28. LEO Pharma supports the FDA's selection of psoriasis as a priority disease
29. LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease
30. J&J -STELARA Receives European Commission Approval For Treatment Of Adolescents With Moderate-To-Severe Psoriasis In Europe; Approval provides new therapeutic option for plaque psoriasis patients aged 12 and older for whom limited approved treatment
31. New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar, Provides Rapid Itch Relief for Psoriasis Patients
32. New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar, Provides Rapid Itch Relief for Psoriasis Patients
33. LEO Pharma A/S announces regulatory submission of ENSTILAR for psoriasis in Europe
34. Investigators at University of Bari Detail Findings in Parasitology (Ixodes ventalloi: morphological and molecular support for species integrity)
35. LEO Pharma announces US regulatory submission of the first aerosol foam for psoriasis
36. LEO Pharma Announces New Drug Application Submission of the First Aerosol Foam for Plaque Psoriasis
37. MADISON ELECTION RESULTS: All but 1 candidate elected
38. New Findings From The Psoriasis Longitudinal Assessment And Registry (PSOLAR); Persistence of STELARA (ustekinumab) Significantly Better than Anti-TNFs in Treatment of Psoriasis According to Observational Study Analysis
39. Janssen Submits Application Seeking Approval Of STELARA In European Union For Pediatric Plaque Psoriasis
40. O-State softball splits
41. Findings from Institute for Cancer Research and Treatment (IRCCS) Provides New Data about Tissue Engineering (A Predictive Model for the Elastic Properties of a Collagen-Hydroxyapatite Porous Scaffold for Multi-Layer Osteochondral Substitutes)
42. -JNJ -STELARA Receives CHMP Positive Opinion For Treatment Of Psoriatic Arthritis
43. Janssen Submits Applications Requesting Approval Of STELARA In U.S. And Europe For Treatment Of Active Psoriatic Arthritis
44. Psoriasis Mandate Results Released to Mark World Psoriasis Day
45. Research from Walloon Agricultural Research Center Reveals New Findings on Genomic Research (Gene expression profiling by cDNA-AFLP reveals potential candidate genes for partial resistance of 'President Roulin' against Venturia inaequalis)
46. Researchers from School of Medicine Report Details of New Studies and Findings in the Area of Type 2 Diabetes (All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation ...)
47. Studies by C. Godino and Co-Authors Describe New Findings in Cardiology Research (One-year outcome of biolimus eluting stent with biodegradable polymer in all comers: The Italian Nobori Stent Prospective Registry)
48. New Findings on Glutamic Acid from Vrije University Summarized (Binding and potential-triggered release of L-glutamate with molecularly imprinted polypyrrole in neutral pH solutions)
49. Findings from University of Bern in the Area of Campylobacter jejuni Described (Genotypes and Antibiotic Resistances of Campylobacter jejuni Isolates from Cattle and Pigeons in Dairy Farms)
50. Researchers at Santa Lucia Foundation Report New Data on Mononuclear Leukocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.